Annual Accounts Payable
$2.94 B
-$743.00 M-20.15%
December 1, 2024
Summary
- As of February 26, 2025, ABBV annual accounts payable is $2.94 billion, with the most recent change of -$743.00 million (-20.15%) on December 1, 2024.
- During the last 3 years, ABBV annual accounts payable has risen by +$63.00 million (+2.19%).
- ABBV annual accounts payable is now -20.15% below its all-time high of $3.69 billion, reached on December 31, 2023.
Performance
ABBV Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
N/A
December 1, 2024
Summary
- ABBV quarterly accounts payable is not available.
Performance
ABBV Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ABBV Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.1% | - |
| 3 y3 years | +2.2% | - |
| 5 y5 years | +102.8% | - |
ABBV Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.1% | +2.2% | ||
| 5 y | 5-year | -20.1% | +102.8% | ||
| alltime | all time | -20.1% | +725.4% |
AbbVie Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.94 B(-20.1%) | - |
| Dec 2023 | $3.69 B(+25.7%) | $3.69 B(+25.7%) |
| Dec 2022 | $2.93 B(+1.8%) | $2.93 B(+1.8%) |
| Dec 2021 | $2.88 B(+26.6%) | $2.88 B(+26.6%) |
| Dec 2020 | $2.28 B(+56.7%) | $2.28 B(+56.7%) |
| Dec 2019 | $1.45 B(-6.1%) | $1.45 B(-6.1%) |
| Dec 2018 | $1.55 B(+4.9%) | $1.55 B(+4.9%) |
| Dec 2017 | $1.47 B(+4.8%) | $1.47 B(+4.8%) |
| Dec 2016 | $1.41 B(-11.9%) | $1.41 B(-11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $1.60 B(+14.0%) | $1.60 B(+14.0%) |
| Dec 2014 | $1.40 B(+50.2%) | $1.40 B(+50.2%) |
| Dec 2013 | $933.00 M(+67.8%) | $933.00 M(+67.8%) |
| Dec 2012 | $556.00 M(+33.3%) | $556.00 M(+31.2%) |
| Sep 2012 | - | $423.91 M(+25.7%) |
| Jun 2012 | - | $337.12 M(-29.2%) |
| Mar 2012 | - | $476.13 M(+14.2%) |
| Dec 2011 | $417.00 M(+16.9%) | $417.00 M |
| Dec 2010 | $356.78 M | - |
FAQ
- What is AbbVie annual accounts payable?
- What is the all time high annual accounts payable for AbbVie?
- What is AbbVie annual accounts payable year-on-year change?
- What is the all time high quarterly accounts payable for AbbVie?
What is AbbVie annual accounts payable?
The current annual accounts payable of ABBV is $2.94 B
What is the all time high annual accounts payable for AbbVie?
AbbVie all-time high annual accounts payable is $3.69 B
What is AbbVie annual accounts payable year-on-year change?
Over the past year, ABBV annual accounts payable has changed by -$743.00 M (-20.15%)
What is the all time high quarterly accounts payable for AbbVie?
AbbVie all-time high quarterly accounts payable is $3.69 B